Pemazyre (R) (Pemigatinib) is available in Germany for the Treatment of Adults with locally advanced or metastatic Cholangiocarcinoma with Fusion or Rearrangement of the Fibroblast Growth Factor Receptor 2 (FGFR2)

首页> 外文期刊>Oncology research and treatment. >Pemazyre (R) (Pemigatinib) is available in Germany for the Treatment of Adults with locally advanced or metastatic Cholangiocarcinoma with Fusion or Rearrangement of the Fibroblast Growth Factor Receptor 2 (FGFR2)

【24h】

Pemazyre (R) (Pemigatinib) is available in Germany for the Treatment of Adults with locally advanced or metastatic Cholangiocarcinoma with Fusion or Rearrangement of the Fibroblast Growth Factor Receptor 2 (FGFR2)

机译：PemazyRe（R）（Pemigatinib）可在德国提供，用于治疗具有局部晚期或转移性胆管癌的成虫，融合或重排成纤维细胞生长因子受体2（FGFR2）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Oncology research and treatment.》 |2021年第6期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
入库时间 2022-08-20 18:45:42

相似文献

外文文献
中文文献
专利

1. Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 protein in the hippocampus in rats exhibiting chronic stress-induced depression [J] . Gonglin Hou, Mingming Tang 中国神经再生研究：英文版 . 2011,第013期
2. Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 protein in the hippocampus in rats exhibiting chronic stress-induced depression [J] . Gonglin Hou, Mingming Tang 中国神经再生研究（英文版） . 2011,第013期
3. RNA interference affects tumorigenicity and expression of insulin-like growth factor-1, insulin-like growth factor-1 receptor, and basic fibroblast growth factor-2 in rat C6 glioma cells [J] . Wanli Dong, Jin Hu, Shaoyan Hu, 中国神经再生研究（英文版） . 2009,第008期
4. Incyte announces European Commission Approval of Pemazyre (R) (Pemigatinib) for the Treatment of Adults with locally advanced or metastatic Cholangiocarcinoma and Fusions or Rearrangements in the Fibroblast Growth Factor Receptor-2 (FGFR2) Gene [J] . Oncology research and treatment. . 2021,第5期

机译：Incyte宣布欧洲委员会批准PemazyRe（群岛）（彭妥替尼），用于治疗局部晚期或转移性胆管癌和融合的成虫生长因子受体-2（FGFR2）基因的融合或重排
5. Positive CHMP Vote for Pemigatinib for the Treatment of Adults with pre-treated, locally advanced or metastatic Cholangiocarcinoma with Fusion or Rearrangement of Fibroblast Growth Factor Receptor 2 [J] . Oncology research and treatment. . 2021,第3期

机译：斑米格替尼的阳性CHMP投票用于治疗具有预处理，局部晚期或转移性胆管癌的成虫，融合或重排成纤维细胞生长因子受体2
6. Identifying fibroblast growth factor receptor genetic alterations using RNA‐based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcinoma who may benefit from erdafitinib treatment [J] . Songbai Wang, Mike Burgess, Christopher Major, The Journal of Pathology: Clinical Research . 2020,第3期

机译：鉴定使用RNA的测定在转移或局部晚期，手术不可切除的尿路上皮癌患者中使用RNA的测定，核癌癌的成纤维细胞生长因子受体遗传改变
7. A COMPUTATIONAL MODEL OF FIBROBLAST GROWTH FACTOR-2 BINDING TO ISOLATED AND INTACT CELL SURFACE RECEPTORS: EFFECTS OF FIBROBLAST GROWTH FACTOR-2 CONCENTRATION, FLOW AND DELIVERY MODE [C] . Nisha S Patel, Alisa Morss Clyne ASME summer bioengineering conference;SBC2012 . 2012

机译：成纤维细胞生长因子-2与分离的完整细胞表面受体结合的计算模型：成纤维细胞生长因子-2浓度，流量和递送模式的影响
8. Indirect Costs Associated with Human Epidermal Growth Factor Receptor Positive (HER2+) Metastatic Breast Cancer [D] . Wright, Phoebe. 2020

机译：与人表皮生长因子受体阳性（HER2 +）转移性乳腺癌相关的间接成本
9. Identifying fibroblast growth factor receptor genetic alterations using RNA‐based assays in patients with metastatic or locally advanced surgically unresectable urothelial carcinoma who may benefit from erdafitinib treatment [O] . Songbai Wang, Mike Burgess, Christopher Major, 2020

机译：使用基于RNA的检测方法鉴定可能受益于erdafitinib的转移性或局部晚期手术无法切除的尿路上皮癌患者中的成纤维细胞生长因子受体基因改变
10. Identifying fibroblast growth factor receptor genetic alterations using RNA‐based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcinoma who may benefit from erdafitinib treatment [O] . Songbai Wang, Mike Burgess, Christopher Major, 2020

机译：鉴定使用RNA的测定在转移或局部晚期，手术不可切除的尿路上皮癌患者中使用RNA的测定，核癌癌的成纤维细胞生长因子受体遗传改变
11. Markers of Fibroblast Growth Factor Family-Mediated Growth Signal Transduction asDeterminants of Successful Hormonal Therapy for Patients with Estrogen Receptor Positive Breast Cancer [R] . Kern, F. G. 1995

机译：成纤维细胞生长因子家族介导的生长信号转导标志物作为雌激素受体阳性乳腺癌患者成功激素治疗的决定因素

Pemazyre (R) (Pemigatinib) is available in Germany for the Treatment of Adults with locally advanced or metastatic Cholangiocarcinoma with Fusion or Rearrangement of the Fibroblast Growth Factor Receptor 2 (FGFR2)

著录项

相似文献

相关主题

期刊订阅